A5078872348- Breast Cancer Treatment Studies
- Cancer Treatment and Pharmacology
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Advanced Breast Cancer Therapies
- Chronic Obstructive Pulmonary Disease (COPD) Research
Centro Universitário do Maranhão
2024
Hospital de São João
2022
<b>Introduction:</b> Data about the impact of COVID-19 on patients with fibrotic ILD are limited. These have impaired lung function and increased risk acute exacerbation driven by viral infection, so is particular concern. <b>Aim:</b> To evaluate SARS-CoV-2 infection previous ILD. <b>Methods:</b> Single-center retrospective study including adult infection. Clinical, imaging, respiratory functional data, pre post were revised. <b>Results:</b> A total 49 (median age 68.4±11.1 years, 61.2%...
Triple-negative breast cancer (TNBC) is a subtype caused by mutation in the BRCA 1 gene, which responsible for components of DNA. In this histological type cancer, estrogen, progesterone, and HER2 protein receptors are absent, making it very aggressive, with great metastatic potential lack therapies, requiring surgical intervention neoadjuvant approach. way, study aims to list discuss effectiveness different treatments triple-negative cancer. This systematic review A search was carried out...